Role of myeloperoxidase-mediated modification of human blood lipoproteins in atherosclerosis development

Bull Exp Biol Med. 2007 Sep;144(3):428-31. doi: 10.1007/s10517-007-0346-x.

Abstract

The mechanism of interaction of hypochlorite and hypobromite formed in myeloperoxidase catalysis with lipids of human blood low-density lipoprotein is described. Both agents react with unsaturated lipids via two mechanisms: molecular (with the formation of mainly chloro- or bromohydrins and lysophospholipids) and free-radical (paralleled by lipid peroxidation). These reactions modify physicochemical properties of low-density lipoproteins and disorder their lipid-transporting function thus initiating early stages of atherosclerosis development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis / blood*
  • Free Radicals / metabolism
  • Humans
  • Lipid Peroxidation
  • Lipoproteins, LDL / chemistry
  • Lipoproteins, LDL / metabolism*
  • Molecular Structure
  • Peroxidase / metabolism*

Substances

  • Free Radicals
  • Lipoproteins, LDL
  • Peroxidase